Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Teva pharmaceutical industries ltd save search
Aflibercept 8 mg Meets Primary Endpoints in Two Global Pivotal Trials for DME and wAMD, with a Vast Majority of Patients Maintained on 12- and 16-week Dosing Intervals
Published: 2022-09-08 (Crawled : 13:20) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
REGN | News | $909.33 0.22% 140K
|
Health Technology
|
| O: 15.18%
H: 4.65%
C: 3.18%
trials global
Press Release: Dupixent® (dupilumab) late-breaking Phase 3 data at EADV 2022 showed significant improvements in signs and symptoms of prurigo nodularis
Published: 2022-09-08 (Crawled : 16:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
REGN | News | $909.33 0.22% 140K
|
Health Technology
|
| O: 15.18%
H: 4.65%
C: 3.18%
dupixent
Dupixent® (dupilumab) Late-breaking Phase 3 Data at the EADV 2022 Congress Showed Significant Improvements in Signs and Symptoms of Prurigo Nodularis
Published: 2022-09-08 (Crawled : 18:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
REGN | News | $909.33 0.22% 140K
|
Health Technology
|
| O: 15.18%
H: 4.65%
C: 3.18%
dupixent
Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share
Published: 2024-02-26 (Crawled : 10:00) - globenewswire.com
ALVO | $13.65 1.87% 120K
|
n/a
|
| O: 11.35%
H: 0.84%
C: -3.25%
KMDA | $5.1 7.6K
|
Health Technology
|
| O: 0.0%
H: 1.6%
C: -0.49%
million
Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
Published: 2024-01-19 (Crawled : 17:00) - globenewswire.com
ALVO | $13.65 1.87% 120K
|
n/a
|
| O: 6.64%
H: 11.54%
C: 8.1%
KMDA | $5.1 7.6K
|
Health Technology
|
| O: -0.85%
H: 1.46%
C: 0.69%
avt02 avt04 license update
Oramed Pharmaceuticals Appoints Chief Legal Officer
Published: 2021-12-08 (Crawled : 13:30) - biospace.com/
ORMP A | $2.34 -0.43% 23K
|
Health Technology
|
| O: 5.82%
H: 3.16%
C: 0.82%
Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to Board of Directors
Published: 2024-02-08 (Crawled : 13:00) - globenewswire.com
ACRV | $9.45 -3.77% 40K
|
|
| O: 5.75%
H: 0.0%
C: -8.29%
VIGL | $2.65 27K
|
|
| O: 1.05%
H: 1.52%
C: -1.39%
therapeutics
Teva Reports Second Quarter 2023 Financial Results
Published: 2023-08-02 (Crawled : 15:00) - biospace.com/
TEVA | $12.935 -0.58% 3.2M
|
Health Technology
|
| O: 5.55%
H: 8.46%
C: 5.71%
teva financial results
Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Association Annual Meeting
Published: 2022-05-17 (Crawled : 12:20) - biospace.com/
TEVA | $12.935 -0.58% 3.2M
|
Health Technology
|
| O: 4.77%
H: 4.8%
C: 3.32%
research
Teva Announces New Findings Highlighting Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Address Asthma Treatment Challenges
Published: 2022-05-17 (Crawled : 12:20) - biospace.com/
TEVA | $12.935 -0.58% 3.2M
|
Health Technology
|
| O: 4.77%
H: 4.8%
C: 3.32%
proair treatment potential
Regeneron Reports Second Quarter 2022 Financial and Operating Results
Published: 2022-08-03 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -2.6%
H: 0.0%
C: -0.76%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.17%
H: 0.12%
C: -1.29%
REGN | News | $909.33 0.22% 140K
|
Health Technology
|
| O: 4.36%
H: 3.91%
C: 1.46%
results
Novel Costimulatory Bispecific Antibody Shows Encouraging Anti-tumor Activity When Combined with PD-1 Inhibitor Libtayo® (cemiplimab) in Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
Published: 2022-08-03 (Crawled : 11:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -2.6%
H: 0.0%
C: -0.76%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.17%
H: 0.12%
C: -1.29%
REGN | News | $909.33 0.22% 140K
|
Health Technology
|
| O: 4.36%
H: 3.91%
C: 1.46%
libtayo antibody cancer prostate cancer pd-1 inhibitor
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | News | $140.3 1.5K
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
VTRS | News A | $11.37 0.09% 1.2M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | News | $40.755 -1.18% 660K
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | News | $168.51 -0.61% 920K
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
PBYI | $4.87 -5.07% 140K
|
Health Technology
|
| O: -0.1%
H: 2.31%
C: -1.26%
AZN | News | $71.065 0.3% 3.2M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
AMGN | News | $274.065 0.19% 570K
|
Health Technology
|
| O: 0.44%
H: 0.2%
C: -0.55%
drug breast expected cancer pipeline therapeutics growth market
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-01-30 (Crawled : 23:00) - prnewswire.com
ALPMF | News | $9.5 1.2K
|
Health Technology
|
| O: 4.34%
H: 0.0%
C: 0.0%
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | News | $140.3 1.5K
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
ALPMY | News | $9.49 480K
|
Manufacturing
|
| O: 0.0%
H: 1.38%
C: 0.26%
VTRS | News A | $11.37 0.09% 1.2M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | News | $40.755 -1.18% 660K
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | News | $168.51 -0.61% 920K
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
AZN | News | $71.065 0.3% 3.2M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
market
Teva Launches New “Pivot to Growth” Strategy
Published: 2023-05-18 (Crawled : 13:20) - biospace.com/
TEVA | $12.935 -0.58% 3.2M
|
Health Technology
|
| O: 3.94%
H: 3.67%
C: -2.25%
teva
New Phase 3 Analyses Show That a Single Dose of REGEN-COV® (casirivimab and imdevimab) Provides Long-term Protection Against COVID-19
Published: 2021-11-08 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
REGN | News | $909.33 0.22% 140K
|
Health Technology
|
| O: 3.88%
H: 0.78%
C: 0.68%
covid casirivimab phase 3
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-09 (Crawled : 13:30) - biospace.com/
EGRX | $4.565 -4.3% 29K
|
Health Technology
|
| O: 3.87%
H: 1.76%
C: 0.69%
financial results report results
Lymphoma Treatment Global Market to Reach $18.5 Billion by 2027 at a CAGR of 8.89%
Published: 2022-11-10 (Crawled : 13:00) - prnewswire.com
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: 2.34%
H: 2.51%
C: 2.29%
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 1.09%
H: 0.48%
C: 0.4%
BMY | $48.76 -0.47% 3.9M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
ABT | News | $106.78 -0.75% 2M
|
Health Technology
|
| O: 3.59%
H: 1.37%
C: 1.16%
treatment global market
Global Genitourinary Drugs Market Research Report to 2027 - Increasing Prevalence of Genitourinary Disorders is Driving Growth
Published: 2022-04-26 (Crawled : 14:00) - prnewswire.com
ALPMF | News | $9.5 1.2K
|
Health Technology
|
| O: 2.56%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 480K
|
Manufacturing
|
| O: 0.13%
H: 0.06%
C: -0.69%
PFE | News 4 | $26.25 -0.27% 9.9M
|
Health Technology
|
| O: 3.08%
H: 0.0%
C: 0.0%
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
|
| O: 0.47%
H: 0.83%
C: -1.44%
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: 2.0%
H: 0.0%
C: 0.0%
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 0.34%
H: 1.41%
C: -1.17%
IONS | $42.1 0.62% 290K
|
Health Technology
|
| O: -0.12%
H: 0.07%
C: -5.13%
research report growth market drug
Retinal drugs market size to increase by USD 7.27579 billion; North America to account for 42% of market growth - Technavio
Published: 2023-02-08 (Crawled : 12:20) - prnewswire.com
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
|
| O: 0.72%
H: 0.52%
C: -0.08%
ALC | $79.605 -1.43% 240K
|
Health Technology
|
| O: 0.28%
H: 0.21%
C: -0.41%
ABBV | News | $168.51 -0.61% 920K
|
Health Technology
|
| O: 0.19%
H: 0.65%
C: -0.55%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: 0.0%
MGTX | $4.865 -1.32% 63K
|
Health Technology
|
| O: -1.14%
H: 4.62%
C: -0.77%
america growth market
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $1.88 60.68% 98M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.